National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
CEFTAZIDIME FOR INJECTION
Definition:
INC 37348 CANCELLED/REPLACED BY ,INC 42844, FIIG A34300, APP-KEY A , ON 122396
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC00007-5085-11 | 93544 | A | 3 | 2 | 6 | 54 | ||
| TAZICEF INJECTION | 93544 | A | 5 | 1 | 6 | 54 |
CAGE Information
| Code | Company |
|---|---|
| 93544 | GLAXOSMITHKLINE HOLDINGS AMERICAS IN |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS |
| FEAT | SPECIAL FEATURES | PIGGYBACK VIAL |
| PKTY | UNIT PACKAGE TYPE | PACKAGE |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| AGXW | PHYSICAL FORM | POWDER |
| CSGS | ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 GRAMS CEFTAZIDIME, ANHYDROUS ACTIVE INGREDIENT |